James C Momtazee insider trades
Open-market stock purchases and sales by James C Momtazee, Director at Roivant Sciences Ltd, from SEC Form 4 filings since Aug 25, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 16, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | — |
| Sep 16, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | — |
| Sep 10, 2026 | ROIV Roivant Sciences Ltd | Sold (not open market) | $119K |
| Jul 17, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | — |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Jun 22, 2026 | BBIO BridgeBio Pharma, Inc | Bought (not open market) | — |
| Apr 17, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | — |
| Apr 17, 2026 | ROIV Roivant Sciences Ltd | Sold (not open market) | $2.8K |
| Jan 20, 2026 | ROIV Roivant Sciences Ltd | Bought (not open market) | — |
| Jan 20, 2026 | ROIV Roivant Sciences Ltd | Sold (not open market) | $2.8K |
Companies traded
- ROIV Roivant Sciences Ltd: other filings, last Sep 16, 2026
- BBIO BridgeBio Pharma, Inc: 1 buy, last Jun 22, 2026
- PRAH PRA Health Sciences, Inc: other filings, last Jul 1, 2021
- MAAC Montes Archimedes Acquisition Corp: other filings, last Nov 20, 2020
- ENTL Entellus Medical Inc: other filings, last Feb 28, 2018
- JAZZ Jazz Pharmaceuticals plc: 1 sale, last Aug 13, 2013